Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $23.6200 (-7.99%) ($23.4200 - $23.6200) on Wed. Jan. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.82% (three month average) | RSI | 28 | Latest Price | $23.6200(-7.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(64%) IBUY(62%) IWC(62%) IWM(61%) | Factors Impacting EDIT price | EDIT will decline at least -1.91% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-9%) IGOV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.91% (StdDev 3.82%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $11.57(-51.02%) | Resistance Level | $27.27 | 5 Day Moving Average | $24.9(-5.14%) | 10 Day Moving Average | $25.68(-8.02%) | 20 Day Moving Average | $27.27(-13.38%) | To recent high | -42% | To recent low | 0% | Market Cap | $1.467b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |